Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

30 mai 2018 07h30 HE | Source: Marinus Pharmaceuticals, Inc.

Marinus Pharmaceuticals to Present at Upcoming Investor Conferences

RADNOR, Pa., May 30, 2018 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS) (the “Company”), a biopharmaceutical company dedicated to the development of innovative therapeutics to...
14 mai 2018 07h30 HE | Source: Marinus Pharmaceuticals, Inc.

Marinus Pharmaceuticals to Present at the UBS Global Healthcare Conference

RADNOR, Pa., May 14, 2018 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and...
02 mai 2018 07h30 HE | Source: Marinus Pharmaceuticals, Inc.

Marinus Pharmaceuticals Provides Business Update and First Quarter 2018 Financial Results

RADNOR, Pa., May 02, 2018 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS) (“Marinus” or “Company”), a biopharmaceutical company dedicated to the development of innovative...
08 mars 2018 07h30 HE | Source: Marinus Pharmaceuticals, Inc.

Marinus Pharmaceuticals to Present at the Barclays Global Healthcare Conference

RADNOR, Pa., March 08, 2018 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and...
06 mars 2018 07h30 HE | Source: Marinus Pharmaceuticals, Inc.

Marinus Pharmaceuticals Provides Business Update and 2017 Financial Results

RADNOR, Pa., March 06, 2018 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and...
07 févr. 2018 07h30 HE | Source: Marinus Pharmaceuticals, Inc.

Marinus Pharmaceuticals to Attend Upcoming Investor Conferences

RADNOR, Pa., Feb. 07, 2018 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS) (the “Company”), a biopharmaceutical company dedicated to the development of innovative therapeutics to...
13 déc. 2017 07h30 HE | Source: Marinus Pharmaceuticals, Inc.

Marinus Pharmaceuticals Added to NASDAQ Biotechnology Index

RADNOR, Pa., Dec. 13, 2017 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS) (the “Company”), a biopharmaceutical company dedicated to the development of innovative therapeutics to...
31 oct. 2017 07h30 HE | Source: Marinus Pharmaceuticals, Inc.

Marinus Pharmaceuticals Provides Business Update and Reports Third Quarter 2017 Financial Results

RADNOR, Pa., Oct. 31, 2017 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS) (the “Company”), a biopharmaceutical company dedicated to the development of innovative therapeutics to...
21 sept. 2017 16h01 HE | Source: Marinus Pharmaceuticals, Inc.

Marinus Pharmaceuticals to Present at the Cantor Fitzgerald Global Healthcare Conference

RADNOR, Pa., Sept. 21, 2017 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and...
19 sept. 2017 16h01 HE | Source: Marinus Pharmaceuticals, Inc.

Marinus Pharmaceuticals Announces closing of Public Offering of Common Stock and full exercise of underwriter’s option to purchase additional shares

RADNOR, Pa., Sept. 19, 2017 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS) (“Marinus” or the “Company”) announced the closing of an underwritten public offering of 10,733,334 shares...

Page précédente